Gero is a data-driven longevity company founded by researchers and entrepreneurs experienced in physics, biology and data science. Our goal is to extend healthy lifespan and delay age-related health issues. We identify anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models. Being an IP-based deep tech company, we publish extensively in peer review and have a developing longevity patent portfolio.